BAT Bangladesh Reports Decreased Income, Increased Earnings and Sales

Aug.02.2023

BAT Bangladesh, the leading cigarette player, reported a decrease in income for April-June 2023, but overall earnings improved.

BAT Bangladesh, the leading player in the cigarette industry in Bangladesh, reported a decrease in income for the period of April-June 2023. The company recorded a total income of Tk 493 crore, compared to Tk 496 crore in the same period last year.

However, when considering their earnings for the first half of the year, including the second quarter, BAT Bangladesh's overall earnings stood at Tk 949 crore. This was an increase from Tk 913 crore in the same period last year.

The earnings per share (EPS) of the tobacco products manufacturer also increased by 4 percent to Tk 17.59 in January-June. The company attributed this growth to an increase in volume and higher leaf export.

Despite the financial performance, shares of BAT Bangladesh remained constant at Tk 518.7 on the Dhaka Stock Exchange.

Regarding sales, BAT Bangladesh reported a total sales of Tk 21,229 crore for the first half of 2023, experiencing a 14 percent year-on-year growth. This information was revealed through the company's unaudited financial statement released recently.

In the April-June period, the multinational company recorded a 15 percent increase in sales, reaching Tk 11,329 crore.

Overall, BAT Bangladesh has seen mixed results in their recent financial report. While they experienced a decline in income for April-June, their overall earnings for the first half of the year showed improvement. The rise in sales can be attributed to the company's volume growth and higher leaf export. However, the market response seemed to be relatively stable, with shares remaining unchanged on the Dhaka Stock Exchange.

#Europe #Legislation #Open system e-cigarettes #Alemania #Bangladesh #British American Tobacco (BAT)#Report

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Glas, the FDA, and the Future of Flavored ENDS

Glas, the FDA, and the Future of Flavored ENDS

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension

A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.

Feb.09 by 2FIRSTS.ai

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts

2Firsts has learned that France’s national health authority, the Haute Autorité de Santé (HAS), confirmed the role of e-cigarettes will be addressed in updated national smoking-cessation guidelines expected by the end of 2026. HAS said the recommendations will focus on clinical and public-health considerations, will not set technical standards for vaping products, and that current studies are insufficient to clearly assess risks and benefits across different product categories.

Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products

Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products

Arizona state Sen. Shawnna Bolick introduced SB 1397 to curb illicit vapes by tracing product origins, intercepting illegal shipments, and cracking down on retailers that violate state law. The proposal would require manufacturers to hold a state license to sell in Arizona, with fines up to $10,000 for unlicensed sales.

Jan.30 by 2FIRSTS.ai

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.

Mar.04 by 2FIRSTS.ai

China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products

China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products

Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.

Related Topics

News

Related Read

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts

France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts

Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products

Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

Bonnie Herzog：U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands

China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products

China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products